Mild leukemia refers to the prognostic low-risk group of acute myeloid leukemia, which has a higher chance of cure, but is directly related to the patient’s physical condition and treatment plan. Treatment includes induction therapy and consolidation and maintenance therapy after induction and remission. 1. Low-risk leukemia patients need to actively cooperate with their doctors to undergo chemotherapy to improve their symptoms through chemotherapy that reduces the number and proportion of leukemia cells. Specific drugs include cytarabine and desogazoxazole. 2. After achieving remission, the original regimen should be given to consolidate the maintenance treatment, or be given high-dose cytarabine intensive treatment, which generally has a higher chance of cure than other intermediate-risk or high-risk groups of leukemia. Patients with low-risk leukemia should go to the hospital as soon as possible to avoid delaying the treatment. Specific medication and treatment should follow the doctor’s instructions.